Cresco Labs Will Remain Undervalued Without Any New Synergies (Rating Downgrade)

Alan Sumler1.44K FollowersFollow5ShareSavePlay(7min)CommentsSummaryI am downgrading Cresco Labs from a Hold to Sell due to weak Q4 results and a diminished operational footprint.CRLBF's Q4 revenue declined and net loss widened.The company exited its California operations and it is unclear what synergy will increase revenue.Although the company is undervalued, sector volatility will keep the stock price on the downtrend.nathanphoto/iStock via Getty Images Cresco Labs (OTCQX:CRLBF) reported weak Q4-2025 financial results with decreasing revenue and a high net loss. Q1 outlook is also weak since the company has discontinued its California operations. On the positive side, the company reported free cashThis article was written byAlan Sumler1.44K FollowersFollowWelcome to the home of The Cannabis Report. I cover the cannabis sector and other sectors. I am most interested in technical stock analysis, option strategies, small cap strategies, and emerging markets. Feel free to contact me with any questions about publicly traded stocks in the cannabis industry.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.